Jilin, China

Changchun Tu

This inventor holds 1 USPTO granted patent. Top assignee: Chinese National Human Genome Center at Shanghai. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Changchun Tu. Retrieved from https://idiyas.com/inventor/changchun-tu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Changchun Tu: Innovator in SARS Research

Introduction

Changchun Tu is a notable inventor based in Jilin, China. He has made significant contributions to the field of virology, particularly in understanding the severe acute respiratory syndrome (SARS) virus. His work has implications for both diagnosis and vaccine development.

Latest Patents

Changchun Tu holds 1 patent related to the characterization of the earliest stages of the SARS virus. The patent focuses on the genomic RNA sequences of the earliest SARS coronaviruses. It aims to identify nucleotide positions within the SARS-CoV genomic RNA that are characteristic of different evolutionary stages. This invention is crucial for developing diagnostic kits and vaccines based on the lowered virulence and contagiousness of these early strains.

Career Highlights

Changchun Tu is affiliated with the Chinese National Human Genome Center at Shanghai. His research has been pivotal in advancing our understanding of SARS and its implications for public health. His innovative approach has garnered attention in the scientific community.

Collaborations

He has collaborated with notable colleagues, including Yixue Li and Rui Xu. Their combined efforts have contributed to the advancement of research in the field of infectious diseases.

Conclusion

Changchun Tu's work in SARS research exemplifies the importance of innovation in addressing public health challenges. His contributions are vital for future advancements in diagnostics and vaccine development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…